144 related articles for article (PubMed ID: 6107392)
1. Effects of oral befunolol on heart rate and systolic blood pressure during submaximal exercise in man.
Miki N; Furusho Y; Itaya K; Midorikawa K; Kumagai E; Terasawa M; Ihara S; Matoba T; Toshima H
Jpn Circ J; 1980 Oct; 44(10):783-93. PubMed ID: 6107392
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of a new beta-adrenoceptor blocking drug, befunolol. Cross-over comparison with propranolol on repeated administration.
Ebihara A; Tawara K; Oka T; Ofuji T; Kawahara K
Eur J Clin Pharmacol; 1982; 23(3):189-95. PubMed ID: 6129139
[TBL] [Abstract][Full Text] [Related]
3. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men.
Sklar J; Johnston GD; Overlie P; Gerber JG; Brammell HL; Gal J; Nies AS
Circulation; 1982 May; 65(5):894-9. PubMed ID: 7074750
[TBL] [Abstract][Full Text] [Related]
4. Effect of beta blockade and intrinsic sympathomimetic activity on exercise performance.
Ades PA; Brammell HL; Greenberg JH; Horwitz LD
Am J Cardiol; 1984 Dec; 54(10):1337-41. PubMed ID: 6507309
[TBL] [Abstract][Full Text] [Related]
5. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
Riddell JG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
[TBL] [Abstract][Full Text] [Related]
6. Assessment of beta-blocking activity of trimepranol in man.
Pentikäinen PJ; Neuvonen PJ; Penttilä A
Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464
[TBL] [Abstract][Full Text] [Related]
7. Effects of S-596, a new beta-adrenoceptor blocking agent on the left ventricular performance of normal subjects during exercise.
Nishida K; Niki S; Furukawa K; Yamada C; Sugihara H; Katsume H; Ijichi H
Jpn Heart J; 1985 May; 26(3):437-49. PubMed ID: 2411959
[TBL] [Abstract][Full Text] [Related]
8. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
[TBL] [Abstract][Full Text] [Related]
9. Comparative beta-adrenoceptor blocking effect and pharmacokinetics of bucindolol and propranolol in man.
Maury M; Berdeaux A; Kher A; Duhaze P; Giudicelli JF
Eur J Clin Pharmacol; 1985; 27(6):649-56. PubMed ID: 2859199
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels and effects of metoprolol on blood pressure and heart rate in hypertensive patients after an acute dose and between two doses during long-term treatment.
Bengtsson C; Johnsson G; Regårdh CG
Clin Pharmacol Ther; 1975 Apr; 17(4):400-8. PubMed ID: 235398
[TBL] [Abstract][Full Text] [Related]
11. Effect of betaxolol on heart rate at rest and during exercise.
Kesteloot H; Missotten A; Coupez-Lopinot R; Sluyts R
Acta Cardiol; 1982; 37(2):117-27. PubMed ID: 6125074
[TBL] [Abstract][Full Text] [Related]
12. Effect of beta-blockers on exercise double product (systolic blood pressure x heart rate).
Vukovich RA; Foley JE; Brown B; Willard DA; Buckley M; O'Kelly D; Fitzgerald D; Tormey W; Darragh A
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):167S-172S. PubMed ID: 37871
[TBL] [Abstract][Full Text] [Related]
13. Comparison of kinetic interactions of nadolol and propranolol with cimetidine.
Duchin KL; Stern MA; Willard DA; McKinstry DN
Am Heart J; 1984 Oct; 108(4 Pt 2):1084-6. PubMed ID: 6148867
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the duration of the effect of a single dose of nadolol on the product frequency x tension during exercise (author's transl)].
Donzeau JP; Birmacker A; Bernadet P; Bounhoure JP
Ann Cardiol Angeiol (Paris); 1978 Oct; 27(5):407-9. PubMed ID: 32825
[No Abstract] [Full Text] [Related]
15. Cardiovascular beta-adrenergic blocking effects of bornaprolol in humans: relation to dose and plasma concentration.
Cheymol G; Jaillon P; Lecoq B; Lecoq V; Cheymol A; Krumenacker M
J Cardiovasc Pharmacol; 1987 Jun; 9(6):694-8. PubMed ID: 2442536
[TBL] [Abstract][Full Text] [Related]
16. The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug.
Pringle TH; Deering AH; Scott MG; Harron DW; Shanks RG
Br J Clin Pharmacol; 1987 Apr; 23(4):411-23. PubMed ID: 2883988
[TBL] [Abstract][Full Text] [Related]
17. Acute response to submaximal and maximal exercise consequent to beta-adrenergic blockade: implications for the prescription of exercise.
Wilmore JH; Freund BJ; Joyner MJ; Hetrick GA; Hartzell AA; Strother RT; Ewy GA; Faris WE
Am J Cardiol; 1985 Apr; 55(10):135D-141D. PubMed ID: 3993545
[TBL] [Abstract][Full Text] [Related]
18. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
Vandenbosch H; Piessens J; De Geest H
Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
[TBL] [Abstract][Full Text] [Related]
19. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
[TBL] [Abstract][Full Text] [Related]
20. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
Tomlinson B; Cronin CJ; Graham BR; Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
